Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study

Figure 1

Flow chart of the sample selection, stratified by underlying cardiovascular disease. DM: diabetes mellitus; DPP-4i: dipeptidyl-peptidase IV inhibitor; N: number of patients; SU: sulfonylurea.